Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
We show that high doses of salicylates reverse hyperglycemia, hyperinsulinemia, and dyslipidemia in obese rodents by sensitizing insulin signaling. Activation or overexpression of the IκB kinase β (IKKβ) attenuated insulin signaling in cultured cells, whereas IKKβ inhibition reversed insulin resistance. Thus, IKKβ, rather than the cyclooxygenases, appears to be the relevant molecular target. Heterozygous deletion ( Ikkβ +/− ) protected against the development of insulin resistance during high-fat feeding and in obese Lep ob/ob mice. These findings implicate an inflammatory process in the pathogenesis of insulin resistance in obesity and type 2 diabetes mellitus and identify the IKKβ pathway as a target for insulin sensitization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, inhibition or inactivation of JNK (18,26) or IKK (22,24,25,27) improves insulin sensitivity in various models of insulin resistance in association with reduced inhibitory serine phosphorylation of IRS-1 (18).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [22]
In the citing paper
“Along these lines, numerous insulin-resistant states (e.g., obesity, type 2 diabetes, and lipid/heparin infusion) are associated with increased activation of JNK (18,21) and/or IKK (21)(22)(23)(24)(25) in parallel with inhibitory serine phosphorylation of IRS-1 (18,21).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [22]
In the citing paper
“Accordingly, KO or inhibition of JNK1 or IKKβ prevents insulin resistance in cell and mouse models (18,22,24,25,87) as well as human models (27) of insulin resistance.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [22]
In the citing paper
“JNK (18,21) and IKK (22,25) signaling are upregulated and activated in insulin-resistant human and rodent skeletal muscle.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [22]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,358
A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., & Karin, M. (1997) · Nature · doi:10.1038/41493 · Cited by 2,125
Self-citationZandi, E., Rothwarf, D. M., Delhase, M., Hayakawa, M., & Karin, M. (1997) · Cell · doi:10.1016/s0092-8674(00)80406-7 · Cited by 1,812
Self-citationInhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
Yin, M.-J., Yamamoto, Y., & Gaynor, R. B. (1998) · Nature · doi:10.1038/23948 · Cited by 1,590
Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267
Is Type II diabetes mellitus a disease of the innate immune system?
Pickup, J. C., & Crook, M. A. (1998) · Diabetologia · doi:10.1007/s001250051058 · Cited by 1,041
Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene
Li, Q., Antwerp, D. V., Mercurio, F., Lee, K.-F., & Verma, I. M. (1999) · Science · doi:10.1126/science.284.5412.321 · Cited by 963
The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling
Karin, M., & Delhase, M. (2000) · Seminars in Immunology · doi:10.1006/smim.2000.0210 · Cited by 955
Self-citation
Research works printed but not linked: 2
- Ebstein W., Berl. Klin. Wochnschr. 13, 337 (1876).
- Supplementary Web material is available on Science Online at www.sciencemag.org/cgi/content/full/293/5535/1673/DC1.
Cited by
Items 401–500 of 999
Inflammation and adipose tissue macrophages in lipodystrophic mice
Herrero, L., Shapiro, H., Nayer, A., Lee, J., & Shoelson, S. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905310107 · Cited by 160
“As adipose tissue expands during periods of nutritional excess, at least two inflammatory pathways are activated, the stress kinase, JNK, mediates one and the transcription factor, NF-κB, mediates the other (7, 8).”
BackgroundMethodInfluentialSelf-citationYue, W., Yang, C. S., DiPaola, R. S., & Tan, X.-L. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0337 · Cited by 160
“Interestingly, high doses of salicylates were also reported to decrease insulin signaling by improving insulin sensitivity through the inhibition of phosphorylation of IRS1 and degradation of IkB kinase a and b (49, 50).”
BackgroundFord, R. J., Fullerton, M. D., Pinkosky, S. L., Day, E. A., Scott, J. W., Oakhill, J. S., Bujak, A. L., Smith, B. K., Crane, J. D., Blümer, R. M., et al. (2015) · Biochemical Journal · doi:10.1042/bj20150125 · Cited by 157
Tang, T., Zhang, J., Yin, J., Staszkiewicz, J., Gawronska-Kozak, B., Jung, D. Y., Ko, H. J., Ong, H., Kim, J. K., Mynatt, R., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.068007 · Cited by 159
Liu, H.-Q., Qiu, Y., Mu, Y., Zhang, X.-J., Liu, L., Hou, X.-H., Zhang, L., Xu, X.-N., Ji, A.-L., Cao, R., et al. (2013) · Nutrition Research · doi:10.1016/j.nutres.2013.07.004 · Cited by 159
“IKK-β and NF-κB were suggested to be involved in the etiology of IR and T2DM [40], and recent insights have revealed that SFA activates the MyD88-”
BackgroundUsing mouse models to dissect the genetics of obesity
Brockmann, G. A., & Bevova, M. R. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02703-8 · Cited by 159
Prevalence, predisposition and prevention of type II diabetes
Cheng, D. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-29 · Cited by 158
“The activated PKC in turn phosphorylates and activates other serine kinases such as IKK-β[32]and JNK-1 [33], leading to phosphorylation of serine sites on IRS-1 insulin receptor substrate (IRS) 1 and 2 at Serine/Threonine sites, blunting the insulin signaling pathway[34].”
Lee, J. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0023-8 · Cited by 158
“We and others then showed that NFjB-dependent proinflammatory cytokines, including TNFa and IL-6, mediate obesity/diet- induced insulin resistance, and that anti-inflammatory cytokines such as IL-10 counter-regulate inflammationinduced insulin resistance (Hotamisligil et al. 1993; Cai et al. 2002, 2005; Klover et al.…”
InfluentialSelf-citationChung, S., Brown, J. M., Provo, J. N., Hopkins, R., & McIntosh, M. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508159200 · Cited by 158
Immune Regulation in Obesity-Associated Adipose Inflammation
Han, J. M., & Levings, M. K. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301035 · Cited by 157
Non-alcoholic fatty liver disease: current concepts and management strategies
Adams, D. H., Haydon, G., & Day, C. P. (2006) · Clinical Medicine · doi:10.7861/clinmedicine.6-1-19 · Cited by 159
Gremese, E., Tolusso, B., Gigante, M. R., & Ferraccioli, G. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00576 · Cited by 156
“Conversely, genetic deletion of IKKB or the inhibition of this pathway by salicylates was shown to attenuate insulin resistance in both mice and human beings (15).”
BackgroundShao-Ling, W. A. N. G., Ying, L. I., Wen, Y., Yan-Feng, C. H. E. N., Na, L.-X., Li, S., & Sun, C. (2009) · Biomedical and Environmental Sciences · doi:10.1016/s0895-3988(09)60019-2 · Cited by 176
Taking Diabetes to Heart—Deregulation of Myocardial Lipid Metabolism in Diabetic Cardiomyopathy
Bayeva, M., Sawicki, K. T., & Ardehali, H. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000433 · Cited by 156
Moloney, F., Toomey, S., Noone, E., Nugent, A., Allan, B., Loscher, C. E., & Roche, H. M. (2007) · Diabetes · doi:10.2337/db06-0384 · Cited by 157
“TNF- increases phosphorylation at this site, and the salicylates are known to exert an insulin-sensitizing effect, at least in part through a reduction in serine phosphorylation at this site through reduced I B kinase- expression/activation (45).”
BackgroundRole of Heme Oxygenase in Inflammation, Insulin-Signalling, Diabetes and Obesity
Ndisang, J. F. (2010) · Mediators of Inflammation · doi:10.1155/2010/359732 · Cited by 172
“Importantly, the IKKβ/NF-κB complex plays a critical and fundamental role for immunity and survival [125, 167].”
BackgroundŠoškić, S., Dobutović, B. D., Sudar-Milovanovic, E. M., Obradovic, M. M., Nikolić, D., Djordjevic, J. D., Radak, D. J., Mikhailidis, D. P., & Isenović, E. R. (2011) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401105010153 · Cited by 171
“The pharmacological inhibition or gene disruption of IKK reversed obesity-related IR and fasting hyperglycemia in rodents and humans [81-83].”
BackgroundInsulin Inhibits IL-10–Mediated Regulatory T Cell Function: Implications for Obesity
Han, J. M., Patterson, S. J., Speck, M., Ehses, J. A., & Levings, M. K. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302181 · Cited by 156
“002 ng/ml) (4), whereas serum insulin concentrations in obese hyperinsulinemic humans can increase to as high as 38 ng/ml upon glucose challenge (27).”
Adipose Tissue Inflammation in the Pathogenesis of Type 2 Diabetes
Kohlgruber, A. C., & Lynch, L. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0670-x · Cited by 174
Insulin Resistance and Its Contribution to Colon Carcinogenesis
Komninou, D., Ayonote, A., Richie, J. P., & Rigas, B. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800410 · Cited by 156
Insulin resistance induced by tumor necrosis factor-α in myocytes and brown adipocytes12
Lorenzo, M., Fernández-Veledo, S., Vila-Bedmar, R., Garcia-Guerra, L., De Alvaro, C., & Nieto-Vazquez, I. (2008) · Journal of Animal Science · doi:10.2527/jas.2007-0462 · Cited by 156
Park, J., Choe, S. S., Choi, A. H., Kim, K. H., Yoon, M. J., Suganami, T., Ogawa, Y., & Kim, J. B. (2006) · Diabetes · doi:10.2337/db05-1570 · Cited by 156
“Many studies have also reported that antioxidant drugs and IKK- inhibitors protect against insulin resistance in obesity and type 2 diabetes (27,31,51,52).”
BackgroundSansbury, B. E., Cummins, T. D., Tang, Y., Hellmann, J., Holden, C. R., Harbeson, M. A., Chen, Y., Patel, R. P., Spite, M., Bhatnagar, A., et al. (2012) · Circulation Research · doi:10.1161/circresaha.112.266395 · Cited by 156
Protein Tyrosine Phosphatase 1B (PTP1B) and Obesity
Cho, H. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-407766-9.00017-1 · Cited by 176
Efficacy and Safety of White Willow Bark (Salix alba) Extracts
Shara, M., & Stohs, S. J. (2015) · Phytotherapy Research · doi:10.1002/ptr.5377 · Cited by 167
“In a study involving obese mice, Yuan et al. (2001) demonstrated that salicylates were able to reverse obesity and diet-induced insulin resistance, implicating inflammatory processes in the pathogenesis of insulin resistance and obesity.”
BackgroundAnimal models for diabetes: Understanding the pathogenesis and finding new treatments
King, A., & Bowe, J. E. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.08.108 · Cited by 173
Hansen, J. B., Tonnesen, M., Madsen, A. N., Hagedorn, P., Friberg, J., Grunnet, L. G., Heller, R. S., Nielsen, A. Ø., Størling, J., Baeyens, L., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.09.001 · Cited by 174
“Cytokine exposure and subsequent NFkB activity are implicated in the metabolic syndrome leading to insulin resistance via both central and peripheral pathways (Arkan et al., 2005; Yuan et al., 2001; Cai et al., 2005; Zhang et al., 2008).”
Interleukin-1 Receptor Antagonist: A New Therapy for Type 2 Diabetes Mellitus
Akash, M. S. H., Shen, Q., Rehman, K., & Chen, S. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23057 · Cited by 170
Lessons from animal models of NASH
Diehl, A. M. (2005) · Hepatology Research · doi:10.1016/j.hepres.2005.09.022 · Cited by 162
Resistin as an Intrahepatic Cytokine
Bertolani, C., Sancho‐Bru, P., Failli, P., Bataller, R. A., Aleffi, S., DeFranco, R., Mazzinghi, B., Romagnani, P., Milani, S., Ginès, P., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060081 · Cited by 176
“In rodents with dietinduced or genetic obesity, increased intrahepatic activation of NF- B is associated with up-regulation of proinflammatory cytokines, and inhibition of NF- B ameliorates insulin resistance.(53,54) Accordingly, transgenic mice with low-level, liver-specific activation of NF- B have recently been sho…”
BackgroundColl, T., Jové, M., Rodríguez-Calvo, R., Eyre, E., Palomer, X., Sánchez, R. M., Merlos, M., Laguna, J. C., & Vázquez-Carrera, M. (2006) · Diabetes · doi:10.2337/db05-1494 · Cited by 151
“This relationship between palmitate-activated NF- B and PGC-1 downregulation in skeletal muscle cells is interesting since NF- B has been linked to the fatty acid–induced impairment of insulin action in rodent skeletal muscle (42,43), while palmitateinduced insulin resistance is reportedly prevented by inhibition of t…”
BackgroundFibrogenic impact of high serum glucose in chro nic hepatitis C
Ratziu, V., Munteanu, M., Charlotte, F., Bonyhay, L., & Poynard, T. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00456-2 · Cited by 153
“However, IkB kinase-b activation also initiates NF-kB-mediated transcription of proinflammatory cytokines such as TNF-a, which in turn perpetuates the activation of IkB kinase-b [36].”
BackgroundOn Evolutionary Biology, Inflammation, Infection, and the Causes of Atherosclerosis
Ridker, P. M. (2002) · Circulation · doi:10.1161/circ.105.1.2 · Cited by 151
NF-κB: master regulator of cellular responses in health and disease
Hoffmann, A., Cheng, G., & Baltimore, D. (2025) · Immunity & Inflammation · doi:10.1007/s44466-025-00014-0 · Cited by 193
Ogihara, T., Asano, T., Katagiri, H., Sakoda, H., Anai, M., Shojima, N., Ono, H., Fujishiro, M., Kushiyama, A., Fukushima, Y., et al. (2004) · Diabetologia · doi:10.1007/s00125-004-1391-x · Cited by 153
“An anti-inflammatory agent, salicylate, which stabilises IκB via inhibition of IKK and suppression of NF-κB activation, was shown to restore lipid-induced insulin resistance [49, 50 ].”
BackgroundMowers, J., Uhm, M., Reilly, S. M., Simon, J., Leto, D., Chiang, S.-H., Chang, L., & Saltiel, A. R. (2013) · eLife · doi:10.7554/elife.01119 · Cited by 149
“Although pharmacologic inhibition or genetic ablation of IKKβ defined a role for this kinase in insulin resistance (Yuan et al., 2001; Arkan et al., 2005), the roles of the noncanonical kinases IKKε and TBK1 are less certain.”
BackgroundMediators of cytokine-induced insulin resistance in obesity and other inflammatory settings
Marette, A. (2002) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200207000-00005 · Cited by 149
Shulman, G. I. (2004) · Physiology · doi:10.1152/physiol.00007.2004 · Cited by 149
Obesity and cancer, a case for insulin signaling
Poloz, Y., & Stambolic, V. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.381 · Cited by 165
“Another hypothesis suggests that FFAs induce the pro-inflammatory response through activation of NF-kB signaling and production of proinflammatory cytokines like TNFα, MCP-1, IL6 and IL1β.(180) The development of IR in response to FFAs is thus a complex process, involving deactivation of INSR signaling pathway compone…”
BackgroundProbiotic mixture VSL# 3: An overview of basic and clinical studies in chronic diseases
Cheng, F.-S., Pan, D., Chang, B., Jiang, M., & Sang, L.-X. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i8.1361 · Cited by 147
Gambino, R., Musso, G., & Cassader, M. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.3058 · Cited by 147
Gene silencing in adipose tissue macrophages regulates whole-body metabolism in obese mice
Aouadi, M., Tencerova, M., Vangala, P., Yawe, J. C., Nicoloro, S. M., Amano, S. U., Cohen, J. L., & Czech, M. P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300492110 · Cited by 147
“In light of this evidence, it has been suggested that therapeutics that can attenuate visceral AT inflammation may alleviate the diabetic state (10, 11).”
BackgroundType‐2 diabetes: Current understanding and future perspectives
Pandey, A., Chawla, S., & Guchhait, P. (2015) · IUBMB Life · doi:10.1002/iub.1396 · Cited by 147
“Furthermore, the metabolic changes in type-2 diabetes include impaired endothelial function, subclinical inflammation, changes in adipokines, the development of atherogenic dyslipidemia, increased levels of free fatty acids (FFAs), and changes in thrombosis and fibrinolysis.”
BackgroundInfluentialSriwijitkamol, A., Christ-Roberts, C., Berria, R., Eagan, P., Pratipanawatr, T., DeFronzo, R. A., Mandarino, L. J., & Musi, N. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0677 · Cited by 145
“A role for this pathway in mediating insulin resistance is further strengthened by the findings that inhibition of I B/NF B signaling improves insulin sensitivity (4,11).”
BackgroundRole of T Cells in Malnutrition and Obesity
Gerriets, V. A., & MacIver, N. J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00379 · Cited by 145
“Earlyanimals studies in 2001 showed that salicylates could reverse obesity-associated insulin resistance in both genetically obese and diet-induced obese mice (68, 69), which resulted in decreased NF-κB activation.”
BackgroundLim, J., Iyer, A., Suen, J. Y., Seow, V., Reid, R. C., Brown, L., & Fairlie, D. P. (2013) · The FASEB Journal · doi:10.1096/fj.12-220582 · Cited by 129
“While the C3aRa and C5aRa used here have certain anti-inflammatory properties in animal models of inflammatory diseases (11, 27, 41), other anti-inflammatory agents, such as salicylates, have shown negligible or only very minor benefits in vivo in metabolic syndrome (42).”
BackgroundKeynote review: The adipocyte as a drug discovery target
Nawrocki, A. R., & Scherer, P. E. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03569-5 · Cited by 153
Lycopene inhibits proinflammatory cytokine and chemokine expression in adipose tissue
Gouranton, E., Thabuis, C., Riollet, C., Malezet‐Desmoulins, C., Yazidi, C. E., Amiot, M. J., Borel, P., & Landrier, J. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.04.016 · Cited by 159
“016 pathways (JNK and NF-κB) in adipose tissue [7,8] and increased production of cytokines and chemokines such as interleukin 6 (IL-6), interleukin 1 beta (IL-1 β), tumor necrosis factor alpha (TNFα) and monocyte chemotactic protein 1 (MCP-1), and of acute phase proteins such as C-reactive protein (CRP) [4,5,9–11].”
BackgroundMathew, M., Tay, E., & Cusi, K. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-9 · Cited by 142
“Endothelial dysfunction has been reported to be reversible with lifestyle changes [60], anti-inflammatory agents such as salicylates [61] or by insulin-sensitizers such as thiazolidinediones [62].”
BackgroundThe Macrophage at the Crossroads of Insulin Resistance and Atherosclerosis
Liang, C.-P., Han, S., Senokuchi, T., & Tall, A. R. (2007) · Circulation Research · doi:10.1161/circresaha.107.152165 · Cited by 143
Innate immune activation in obesity
Lumeng, C. N. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.10.002 · Cited by 142
“Pre-clinical studies demonstrate that it can attenuate obesity induced inflammation (Yuan et al., 2001).”
BackgroundWang, J., Wang, C., Li, S., Li, W., Yuan, G., Pan, Y., & Chen, H. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.09.104 · Cited by 149
Caricilli, A. M., Nascimento, P. H., Pauli, J. R., Tsukumo, D. M. L., Velloso, L. A., Carvalheira, J. B., & Saad, M. J. A. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0354 · Cited by 141
Pathogenesis of Type 2 Diabetes Mellitus
Al-Saraj, F. (2015) · InTech eBooks · doi:10.5772/59183 · Cited by 144
“In addition, IKK-β is a mediator of TNF-induced IR [52, 53, 54, 55] demonstrated the TLR4 (Lipopolysaccharide receptor) activation by FFA, plays a critical role in innate immunity and IR in obese human and animals through activation of inflammatory pathways.”
BackgroundO’Neill, C. M., Lu, C. Y., Corbin, K. L., Sharma, P. R., Dula, S. B., Carter, J. D., Ramadan, J. W., Xin, W., Lee, J. K., & Nunemaker, C. S. (2013) · Endocrinology · doi:10.1210/en.2012-2138 · Cited by 153
Self-citationLeucine signaling in the pathogenesis of type 2 diabetes and obesity
Melnik, B. C. (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i3.38 · Cited by 140
Diabesity: An Inflammatory Metabolic Condition
Schmidt, M. I., & Duncan, B. B. (2003) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2003.174 · Cited by 140
“Recent work supports the hypothesis that IKK also induces serine phosphorylation of IRS-1, thus providing a potential link between inflammation and obesity-linked insulin resistance (54, 55).”
BackgroundKarnieli, E., & Armoni, M. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90306.2008 · Cited by 139
“FFAs also attenuate insulin signaling and GLUT4 translocation through activation of the IkB kinase pathway (111).”
BackgroundInflammation in obesity-related diseases
O’Rourke, R. W. (2008) · Surgery · doi:10.1016/j.surg.2008.08.038 · Cited by 161
“mice.(1) Similar evidence implicates inflammation in the pathogenesis of atherosclerosis, steatohepatitis, sleep apnea, asthma, and osteoarthritis.”
Inflammatory Concepts of Obesity
Rocha, V. Z., & Folco, E. J. E. (2011) · International Journal of Inflammation · doi:10.4061/2011/529061 · Cited by 151
“Both JNK and IKK, which are members of two major pro-inflammatory cascades, are likely activated in insulin-resistant states, and thus provide potential connections between inflammation and insulin resistance [127, 130, 131].”
BackgroundInsulin receptor substrate proteins and diabetes
Lee, Y. H., & White, M. F. (2004) · Archives of Pharmacal Research · doi:10.1007/bf02980074 · Cited by 152
Diet-Derived Fatty Acids, Brain Inflammation, and Mental Health
Melo, H. M., Santos, L. E., & Ferreira, S. T. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00265 · Cited by 136
Fatty acids and chronic low grade inflammation associated with obesity and the metabolic syndrome
Cooke, A. A., Connaughton, R. M., Lyons, C. L., McMorrow, A. M., & Roche, H. M. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.04.021 · Cited by 151
Zhu, M. J., Ma, Y., Long, N. M., Du, M., & Ford, S. P. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00309.2010 · Cited by 137
NF‐κB pathway protects cochlear hair cells from aminoglycoside‐induced ototoxicity
Jiang, H., Sha, S., & Schacht, J. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20392 · Cited by 136
“In this context, it is interesting to consider that salicylate has been reported to inhibit NF- B activation in cell culture (Yin et al., 1998; Yuan et al., 2001).”
BackgroundPoulsen, M. M., Fjeldborg, K., Ørnstrup, M. J., Kjær, T. N., Nøhr, M. K., & Pedersen, S. B. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.12.024 · Cited by 143
“Likewise, treating obese and insulin resistant rodents with the anti-inflammatory compound Aspirin demonstrated that inhibition of the inflammatory kinase IKKβ by Aspirin resulted in improved insulin sensitivity, andmoreover, reduced triglyceride and free fatty acid levels [168] Salsalate and Aspirin are chemically re…”
Nitrosative Stress and Pathogenesis of Insulin Resistance
Kaneki, M., Shimizu, N., Yamada, D., & Chang, K. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.1464 · Cited by 132
“:3) ameliorates insulin resistance in high-fat diet–fed mice and in ob/ob mice (118) are genetically obese and diabetic due to leptin deficiency.”
Bettaieb, A., Prieto, M. A. V., Lanzi, C. R., Miatello, R. M., Haj, F. G., Fraga, C. G., & Oteiza, P. I. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.04.011 · Cited by 140
“This is further supported by findings that genetic deficits of JNK or IKK mitigate obesity-induced insulin resistance [44, 45].”
BackgroundAir Pollution as a Risk Factor for Type 2 Diabetes
Rao, X., Patel, P., Puett, R., & Rajagopalan, S. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfu250 · Cited by 132
“In contrast, M1 macrophages in obese subjects produce pro-inflammatory mediators and induce IR through IKK-band JNK-mediated serine phosphorylation of IRS-1 and -2 (Cai et al., 2005; Hirosumi et al., 2002; Yuan et al., 2001).”
BackgroundRole of interleukins in obesity: implications for metabolic disease
Febbraio, M. A. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.02.004 · Cited by 147
Diabetes and Sepsis: Risk, Recurrence, and Ruination
Frydrych, L. M., Fattahi, F., He, K., Ward, P. A., & Delano, M. J. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00271 · Cited by 158
“Metformin, a current widely accepted diabetic drug, has been shown to inhibit release of pro-inflammatory cytokines via IL-1β mechanisms by antagonizing NF-κβ in cells of the vascular wall as well as in macrophages (234).”
BackgroundInfluentialMuoio, D. M., & Koves, T. R. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-083 · Cited by 129
“Even more convincing, inhibition of these serine kinases by pharmacological or genetic interventions has been shown to rescue insulin sensitivity in rodents models of obesity and (or) diabetes (Arkan et al. 2005; Kim et al. 2001, 2004; Yuan et al. 2001).”
BackgroundTurpin-Nolan, S. M., Hoy, A. J., Brown, R. D., Rudaz, C. G., Honeyman, J. E., Matzaris, M., & Watt, M. J. (2010) · Diabetologia · doi:10.1007/s00125-010-1895-5 · Cited by 137
“Other serine/threonine kinases such as JNK and inhibitor of kappa kinase are implicated in the development of insulin resistance [44, 45 ], yet neither kinase was attenuated with ATGL overproduction.”
BackgroundLipocalin 2 is a Regulator Of Macrophage Polarization and NF-κB/STAT3 Pathway Activation
Guo, H., Jin, D., & Chen, X. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1092 · Cited by 129
Molecular mechanisms of lipid‐induced insulin resistance in muscle, liver and vasculature
Krebs, M., & Roden, M. (2005) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00439.x · Cited by 129
Goldfine, A. B., Conlin, P. R., Halperin, F., Koska, J., Permana, P., Schwenke, D., Shoelson, S. E., & Reaven, P. D. (2013) · Diabetologia · doi:10.1007/s00125-012-2819-3 · Cited by 129
“Studies in rodents underscore the importance of activation of the NF-κB pathway in these conditions and have demonstrated that salicylates effectively inhibit inflammation and improve insulin sensitivity and lipid metabolism [10–13].”
Self-citationLeow, M. K., Addy, C., & Mantzoros, C. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021704 · Cited by 148
Skeletal Muscle Stem Cells: Effects of Aging and Metabolism on Muscle Regenerative Function
Jang, Y. C., Sinha, M., Cerletti, M., Dall'Osso, C., & Wagers, A. J. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010652 · Cited by 127
“Global inhibition of this pathway may affect multiple different tissues, including adipose, where NF-kB blockade may inhibit systemic inflammation by decreasing TNF-a levels (Yuan et al. 2001), and skeletal muscle, where reduced NF-kB activation may reverse inflammation mediated muscle atrophy (Cai et al.”
Cipolletta, D., Kolodin, D., Benoist, C. O., & Mathis, D. J. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.06.002 · Cited by 141
“Activation of NF-B [19] and the JUN N-terminal”
BackgroundCapo, F., Wilson, A., & Cara, F. D. (2019) · Microorganisms · doi:10.3390/microorganisms7090336 · Cited by 142
Morino, K., Neschen, S., Bilz, S., Sono, S., Tsirigotis, D., Reznick, R. M., Moore, I., Nagai, Y., Samuel, V., Sebastian, D., et al. (2008) · Diabetes · doi:10.2337/db06-0454 · Cited by 125
Inflammation in the Pathophysiology and Therapy of Cardiometabolic Disease
Donath, M. Y., Meier, D. T., & Böni-Schnetzler, M. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00002 · Cited by 124
Macrophage Polarization and Insulin Resistance: PPARγ in Control
Charo, I. F. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.07.006 · Cited by 147
Molecular pathways disrupted by gestational diabetes mellitus
Nguyen-Ngo, C., Jayabalan, N., Salomon, C., & Lappas, M. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0274 · Cited by 124
Csóka, B., Koscsó, B., Törő, G., Kókai, E., Virág, L., Németh, Z. H., Pacher, P., Bai, P., & Haskó, G. (2013) · Diabetes · doi:10.2337/db13-0573 · Cited by 128
Cytokines and fatty liver diseases
Niederreiter, L., & Tilg, H. (2018) · Liver Research · doi:10.1016/j.livres.2018.03.003 · Cited by 139
Inflammation and Insulin Resistance
Bloomgarden, Z. T. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1922 · Cited by 136
Carnethon, M. R., Fortmann, S. P., Palaniappan, L., Duncan, B. B., Schmidt, M. I., & Chambless, L. E. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg260 · Cited by 134
“Tumor necrosis factoralpha, among other actions, increases IkappaB kinase beta (IKKbeta) activity, which blocks insulin signaling as well as releases nuclear factor kappa beta, which stimulates production of a number of inflammatory mediators (45).”
BackgroundExercise, heat shock proteins and insulin resistance
Archer, A. E., Von Schulze, A. T., & Geiger, P. C. (2018) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2016.0529 · Cited by 122
Radin, M. S., Sinha, S., Bhatt, B. A., Dedousis, N. L., & O'Doherty, R. M. (2007) · Diabetologia · doi:10.1007/s00125-007-0861-3 · Cited by 133
“A proximal target of TLR-4 activity is the NFκB pathway, which itself has been implicated as a mechanism of insulin resistance [1, 10, 12, 13, 15, 16] and is activated by lipids [8, 11, 13, 14].”
BackgroundYan, X., Zhu, M. J., Xu, W., Tong, J. F., Ford, S. P., Nathanielsz, P. W., & Du, M. (2010) · Endocrinology · doi:10.1210/en.2009-0849 · Cited by 122
The Role of Catechins in Regulating Diabetes: An Update Review
Wen, L., Wu, D., Tan, X., Zhong, M., Xing, J., Li, W., Li, D., & Cao, F. (2022) · Nutrients · doi:10.3390/nu14214681 · Cited by 144
“Additionally, animals with IKK genetic abnormalities are protected from developing insulin resistance [52].”
BackgroundDandona, P., & Aljada, A. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02556-0 · Cited by 137
Transcriptional regulation of the GLUT4 gene: from PPAR-γ and FOXO1 to FFA and inflammation
Armoni, M., Harel, C., & Karnieli, E. (2007) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2007.02.001 · Cited by 145
Luan, B., Goodarzi, M. O., Phillips, N. G., Guo, X., Chen, Y.-D. I., Yao, J., Allison, M., Rotter, J. I., Shaw, R., & Montminy, M. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.024 · Cited by 117
“Activation of the inhibitor of kappa B kinase b (IKKb) in macrophages stimulates the release of inflammatory mediators that promote insulin resistance (Arkan et al., 2005; Yuan et al., 2001); indeed, disruption of NF-kB activity through deletion of IKKb increases insulin sensitivity (Arkan et al.”
BackgroundFuentes, L., Rőszer, T., & Ricote, M. (2010) · Mediators of Inflammation · doi:10.1155/2010/219583 · Cited by 119
Lipid Chaperones and Metabolic Inflammation
Furuhashi, M., Ishimura, S., Ota, H., & Miura, T. (2011) · International Journal of Inflammation · doi:10.4061/2011/642612 · Cited by 119
“These pathways lead to the inhibition of insulin signaling [4–6] and a vicious spiral of additional production of inflammatory mediators through transcriptional regulation using activating protein-1 (AP-1) and nuclear factor-kappa B (NF-κB).”
BackgroundNF‐κB as the mediator of metformin's effect on ageing and ageing‐related diseases
Kanigur Sultuybek, G., Soydas, T., & Yenmis, G. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13073 · Cited by 119
Koska, J., Ortega, E., Bunt, J. C., Gasser, A., Impson, J., Hanson, R. L., Forbes, J., de Courten, B., & Krakoff, J. (2009) · Diabetologia · doi:10.1007/s00125-008-1239-x · Cited by 119
“Insulin concentrations in plasma (OGTT) or serum (clamp) were measured by an automated immunoassay (Access; Beckman Instruments).”
BackgroundResultInfluentialThe Role of HMGB1 in the Pathogenesis of Type 2 Diabetes
Wang, Y., Zhong, J., Zhang, X., Liu, Z., Yang, Y., Gong, Q., & Ren, B. (2016) · Journal of Diabetes Research · doi:10.1155/2016/2543268 · Cited by 129
Metadata
- Authors
- Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E.
- Affiliations
- Joslin Diabetes Center (US)
- Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093, USA.
- University of California San Diego (US)
- Corresponding author
- Yuan, Minsheng
- Konstantopoulos, Nicky
- Lee, Jongsoon
- Shoelson, Steven E.
- Venue
- Science
- Published
- 2001-08-31
- Volume
- 293
- Issue
- 5535
- Pages
- 1673-1677
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2031637294
- Cited by
- 1,884
- References
- 26
- Citations by year
- 2026: 16 · 2025: 29 · 2024: 27 · 2023: 36 · 2022: 41 · 2021: 51 · 2020: 51 · 2019: 61 · 2018: 54 · 2017: 70 · 2016: 78 · 2015: 93 · 2014: 109 · 2013: 124 · 2012: 99
- FWCI
- 56.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r29dk045493-05)
- National Institute of Allergy and Infectious Diseases (AI 43477)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 51729, DK45493)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- insulin resistance, obesity, salicylates, IκB kinase β, insulin signaling, inflammation, type 2 diabetes, hyperinsulinemia, hyperglycemia, dyslipidemia, high-fat diet, ob/ob mice, insulin sensitization, cyclooxygenase
- MeSH terms
- Animals, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Blood Glucose, Cell Line, Dietary Fats, Glucose Tolerance Test, Insulin, Insulin Resistance, Lipids, Liver, Male, Mice, Obese, Muscles, Obesity, Phosphorylation, Prostaglandin-Endoperoxide Synthases, Rats, Zucker, Receptor, Insulin, Sodium Salicylate, Tumor Necrosis Factor-alpha, Signal Transduction, Protein Serine-Threonine Kinases, Gene Deletion, Gene Targeting, Mice, Rats, I-kappa B Kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.